Identify the BRAF V600E mutation in formalin-fixed, paraffin-embedded (FFPE) tissue samples with a qualitative molecular detection test designed for in vitro use. This assay supports mutation analysis in human melanoma, colorectal cancer, thyroid cancer, and lung cancer specimens.
With a workflow focused on FFPE sample testing, the assay helps laboratories evaluate BRAF V600E mutation status as part of qualified clinical testing and research applications. Results should be interpreted by trained professionals alongside other clinical and pathological information.
With a workflow focused on FFPE sample testing, the assay helps laboratories evaluate BRAF V600E mutation status as part of qualified clinical testing and research applications. Results should be interpreted by trained professionals alongside other clinical and pathological information.
